ENCePP 10 years of collaboration to strengthen the monitoring of benefits and risks of medicines in Europe.

Expertise and collaboration in pharmacovigilance and pharmacoepidemiology in Europe

Methodological guidance

Governance principles

Increased transparency in high quality, multi-centre, independent non-interventional post-authorisation studies (PAS)

ENCePP Guide on Methodological Standards in Pharmacoepidemiology—a single web resource for methodological English language guidance (6th revision published in July 2017).

ENCePP hosts the public European Union electronic Register of Post-Authorisation Studies (EU PAS Register®).

ENCePP Checklist for Study Protocols

Supporting best practice in study designPromoting transparency on study methods

www.encepp.eu

ENCePP Code of Conduct

Promoting transparency and scientific independence throughout the research process

168 Public institutions and research organisations

18 European countries

83Data sources(by type, July 2017)

31authors

424references selected, commented and updated

4%

84%

2%10%

1145PAS registered (By type, July 2017)

Active surveillance

Observational study

Clinical trial

Other

50%of registered studies were requested by a regulator:

Europe

United States

Rest of the World

5000 views on average per month in 2017 (www.encepp.eu)

850 downloads on average per month in 2017 (www.encepp.eu)

The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) is a network coordinated by the European Medicines Agency (EMA).

The members of this network (the ENCePP partners) are public institutions and contract and research organisations (CRO) involved in research in pharmacoepidemiology and pharmacovigilance.

35%

4%5%23%

10%

19%

4%

Disease registry

Spontaneous reporting database

Prescription event monitoring

Claims/administrative databases

Electronic healthcare records

Medicine registry

Other

40%

6%4%

Not requested

50%